June 28, 2021

Virtual Reality in GI with Brennan Spiegel, MD

47 minutes

In this podcast episode, Brennan Spiegel, MD, MSHS, discusses virtual and augmented reality in gastroenterology from both a clinical and research perspective, as well as his thoughts on the future of the field.

Intro :02
The interview :22
How did you decide to be a doctor? :23
What are your main takeaways from serving as editor of AJG over the last 6 years? 2:46
What was your journey that led to what you’re focusing on now? 5:47
Can you give us a sense of what these words mean when you say “virtual reality” and “augmented reality”? 7:29
As a professor of medicine, a gastroenterologist, a public health advocate and researcher, how did you come to think of this being your area of focus? 10:40
How does this work from a clinical perspective? 15:21
Can you tell us about how the clinical trials are run, what sham VR is and how are these high-quality trials designed? 19:53
Have we studied the biochemical response? 22:13
The discussion of virtual reality and its use in neuromodulation and nerve stimulation 25:07
Where do you think the biggest challenge is in this widespread implementation? 31:34
What about developing VR reimbursement strategies … Have you heard of virtual reality companies approaching things this way? 34:44
How do you think about intellectual property with VR? 37:38
Where do you think we stand in regard to regulatory hurdles? 39:52
Are there any risks? Are these things that are being studied? Are these valid concerns? 42:00
What do you want the listeners to take away from this? What’s the call to action? 44:31
Thank you, Dr. Spiegel 46:27

Brennan Spiegel, MD, MSHS, is the director of health services research for Cedars-Sinai and the director of the Cedars-Sinai Master's Degree Program in health delivery science. He directs the Cedars-Sinai Center for Outcomes Research and Education.

We’d love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc

Disclosures: Berry, Chey and Spiegel report no relevant financial disclosures.

...more

View all episodes

By Sameer K. Berry, MD, and William D. Chey, MD

4.8

3131 ratings

June 28, 2021

Virtual Reality in GI with Brennan Spiegel, MD

47 minutes

Intro :02
The interview :22
How did you decide to be a doctor? :23
What are your main takeaways from serving as editor of AJG over the last 6 years? 2:46
What was your journey that led to what you’re focusing on now? 5:47
Can you give us a sense of what these words mean when you say “virtual reality” and “augmented reality”? 7:29
As a professor of medicine, a gastroenterologist, a public health advocate and researcher, how did you come to think of this being your area of focus? 10:40
How does this work from a clinical perspective? 15:21
Can you tell us about how the clinical trials are run, what sham VR is and how are these high-quality trials designed? 19:53
Have we studied the biochemical response? 22:13
The discussion of virtual reality and its use in neuromodulation and nerve stimulation 25:07
Where do you think the biggest challenge is in this widespread implementation? 31:34
What about developing VR reimbursement strategies … Have you heard of virtual reality companies approaching things this way? 34:44
How do you think about intellectual property with VR? 37:38
Where do you think we stand in regard to regulatory hurdles? 39:52
Are there any risks? Are these things that are being studied? Are these valid concerns? 42:00
What do you want the listeners to take away from this? What’s the call to action? 44:31
Thank you, Dr. Spiegel 46:27